Contact

Our portfolio

ikHerstel

Enhancing post-surgery recovery, ikHerstel offers an e-Health app that provides personalized recovery plans. Their app, based on research from Amsterdam UMC, helps patients recover faster and more effectively. ikHerstel has received significant recognition and funding for their innovative approach. The company is committed to transforming post-operative care through digital health solutions.

  • Institute: Amsterdam UMC
Industry: Digital Health, Rehabilitation
  • Founding year: 2019
Visit website

Want to get in contact about ikHerstel?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
InspectT
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
SigmaScreening
Developing a painless and more accurate mammography technology for breast cancer detection.
DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
InspectT
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
SigmaScreening
Developing a painless and more accurate mammography technology for breast cancer detection.
DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
Explore full AAV portfolio
Contact